This application is the first competitive renewal for the T32 training program in the Department of Surgery at the Albert Einstein College of Medicine. The goal of our program entitled - ?Training of Surgeon Scientists in Basic and Translational Cancer Research? - is to improve the training of future surgeon cancer scientists. With the proposed continuation of this program, we seek to provide a platform to train highly motivated surgical residents with an interest to pursue a career in research and clinical surgery and who aspire to become surgeon scientists with a focus on cancer. Our program is designed for surgical residents in the department of surgery to spend two years dedicated to training in the conduct of basic and translational research. Based on our success to date we seek to expand our initial program from one that focused on the tumor microenvironment to a program that addresses more broadly the cancer biology research programs in the Albert Einstein Cancer Center (AECC). Advances in the understanding of the mechanisms controlling tumor initiation, progression, invasion and metastasis as well as the role of the immune system in tumor growth inhibition are examples of the themes and coordination of the programs in the AECC. By bringing together a team of mentors with a strong track record of research accomplishments as well as sustained experience in training post-graduate fellows, we plan to address an unmet need in the preparation of surgeons for a career in cancer research. Our application includes outstanding faculty mentors and co-mentors representing 5 clinical departments and 4 basic science departments. The 14 faculty members include 12 senior mentors and 2 junior mentors. We have also included in our faculty 4 surgical faculty advisors and two didactic faculty. The training program will consist of two years of laboratory research, formal coursework and participation in relevant journal clubs and seminars. The training will also include participation in the department of surgery?s annual research day and attendance at departmental and professional conferences and relevant workshops. Successful trainees will have submitted at least two abstracts to national meetings and at least one original manuscript for peer review by the completion of the training program. The curriculum is designed to prepare the trainee to pursue a career as a surgeon scientist. The program is structured with a formal evaluation process in place to evaluate trainee, mentor and overall program performance.
Given the important contributions made by investigator-surgeons in the past and the need to continue to address urgent questions in the future, there is a critical need to train surgeons to become scientists. The proposed program is designed for surgical residents to spend two years dedicated to training in the conduct of basic and translational research. The goal of our program is to provide a comprehensive curriculum for training surgical residents to become Surgeon Scientists in Basic and Translational Cancer Research.
|Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80|
|Pastoriza, Jessica M; Karagiannis, George S; Lin, Juan et al. (2018) Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis 35:613-623|
|Entenberg, David; Pastoriza, Jessica M; Oktay, Maja H et al. (2017) Time-lapsed, large-volume, high-resolution intravital imaging for tissue-wide analysis of single cell dynamics. Methods 128:65-77|
|Karagiannis, George S; Pastoriza, Jessica M; Wang, Yarong et al. (2017) Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med 9:|
|von Ahrens, Dagny; Bhagat, Tushar D; Nagrath, Deepak et al. (2017) The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol 10:76|
|Bhagat, Tushar D; Chen, Si; Bartenstein, Matthias et al. (2017) Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/?-Catenin Activation. Cancer Res 77:4846-4857|